- Home
- WELL vs SYK Comparison
WELL vs SYK Comparison
Compare WELL & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WELL | SYK |
|---|---|---|
| Founded | 1970 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.5B | 140.0B |
| IPO Year | 1994 | 1994 |
Fundamental Metrics
Financial Performance| Metric | WELL | SYK |
|---|---|---|
| Price | $205.60 | $339.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $227.09 | ★ $431.08 |
| AVG Volume (30 Days) | ★ 2.6M | 1.7M |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.44% | 1.04% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | 1.39 | ★ 8.40 |
| Revenue | $10,838,034,000.00 | ★ $25,116,000,000.00 |
| Revenue This Year | $28.66 | $9.86 |
| Revenue Next Year | $6.03 | $8.39 |
| P/E Ratio | $148.32 | ★ $40.23 |
| Revenue Growth | ★ 35.63 | 11.16 |
| 52 Week Low | $130.29 | $328.23 |
| 52 Week High | $216.43 | $404.87 |
Technical Indicators
Market Signals| Indicator | WELL | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 54.34 | 27.52 |
| Support Level | $182.12 | N/A |
| Resistance Level | $209.05 | $375.26 |
| Average True Range (ATR) | 3.83 | 8.48 |
| MACD | -1.01 | -5.00 |
| Stochastic Oscillator | 50.65 | 16.58 |
Price Performance
Historical ComparisonAbout WELL Welltower Inc.
Welltower owns a diversified healthcare portfolio of 2,900 in-place properties spread across the senior housing, medical office, and skilled nursing/postacute care sectors. The portfolio includes over 900 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to that of the United States.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.